The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation...

por ten Cate, V., ten Cate, H., Verheugt, F. W. A.
Publicado 2016

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial...

por ten Cate, V., ten Cate, H., Verheugt, F. W. A.
Publicado 2016

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

por Magnette, A., Chatelain, M., Chatelain, B., Ten Cate, H., Mullier, F.
Publicado 2016

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs

por Honickel, M, Grottke, O, Van Ryn, J, Ten Cate, H, Rossaint, R, Spronk, H
Publicado 2014

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model

por Honickel, M, Van Ryn, J, Spronk, HM, Ten Cate, H, Rossaint, R, Grottke, O
Publicado 2014

A Rare Case of Intermittent Claudication Associated with Impaired Arterial Vasodilation

por Posthuma, J. J., Reesink, K. D., Schütten, M., Ghossein, C., Spaanderman, M. E., ten Cate, H., Schep, G.
Publicado 2017

Organisation of care for patients using direct oral anticoagulants

por Gulpen, A. J. W., van Dijk, J. K., Damen, N. L., ten Cate, H., Schalla, S., ten Cate-Hoek, A. J.
Publicado 2020

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements

por Giesen, P. L. A., Gulpen, A. J. W., van Oerle, R., ten Cate, H., Nagy, M., Spronk, H. M. H.
Publicado 2021

The hypercoagulable profile of patients with stent thrombosis

por Loeffen, R, Godschalk, T C, van Oerle, R, Spronk, H M H, Hackeng, C M, ten Berg, J M, ten Cate, H
Publicado 2015

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism

por Mairuhu, ATA, Setiati, TE, Koraka, P, Hack, CE, Leyte, A, Faradz, SMH, ten Cate, H, Brandjes, DPM, Osterhaus, ADME, Reitsma, PH, van Gorp, ECM
Publicado 2005

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study

por Kremers, B. M. M., Daemen, J. H. C., ten Cate, H., Spronk, H. M. H., Mees, B. M. E., ten Cate-Hoek, A. J.
Publicado 2023

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

por Hardy, M., Lecompte, T., Douxfils, J., Lessire, S., Dogné, J. M., Chatelain, B., Testa, S., Gouin-Thibault, I., Gruel, Y., Medcalf, R. L., ten Cate, H., Lippi, G., Mullier, F.
Publicado 2020

Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events

por Olie, R. H., van der Meijden, P. E. J., Vries, M. J. A., Veenstra, L., van ‘t Hof, A. W. J., ten Berg, J. M., Henskens, Y. M. C., ten Cate, H.
Publicado 2021

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

por Kremers, B. M. M., Posma, J. N., Heitmeier, S., Glunz, J., ten Cate, H., Pallares Robles, A., Daemen, J. H. C., ten Cate-Hoek, A. J., Mees, B. M. E., Spronk, H. M. H.
Publicado 2022

Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach

por Lobbes, M. B. I., Kooi, M. E., Lutgens, E., Ruiters, A. W., Lima Passos, V., Braat, S. H. J. G., Rousch, M., Ten Cate, H., van Engelshoven, J. M. A., Daemen, M. J. A. P., Heeneman, S.
Publicado 2010

Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board

por Mulder, B. A., ten Berg, J., ten Cate, H., van Es, N., Hemels, M. E. W., Kappelle, L. J., Bearda Bakker, H. B., de Borst, G. J., Drenth, D. J., Geersing, G. J., Rienstra, M.
Publicado 2020

Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19

por Willems, L.H., Nagy, M., ten Cate, H., Spronk, H.M.H., Groh, L.A., Leentjens, J., Janssen, N.A.F., Netea, M.G., Thijssen, D.H.J., Hannink, G., van Petersen, A.S., Warlé, M.C.
Publicado 2022

Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inf...

por Willems, L H, Nagy, M, Ten Cate, H, Spronk, H M H, Groh, L A, Leentjes, J, Janssen, N A F, Netea, M G, Thijssen, D H J, Hannink, G J, Van Petersen, A S, Warle, M C
Publicado 2021

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

por de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., ten Cate, H., Olie, R. H.
Publicado 2021

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

por Seelig, J., Verheugt, F. W. A., Hemels, M. E. W., Illingworth, L., Lucassen, A., Adriaansen, H., Bongaerts, M. C. M., Pieterse, M., Herrman, J. P. R., Hoogslag, P., Hermans, W., Groenemeijer, B. E., Boersma, L. V. A., Pieper, K., ten Cate, H.
Publicado 2020